DORMATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dormate, and what generic alternatives are available?
Dormate is a drug marketed by Medpointe Pharm Hlc and is included in one NDA.
The generic ingredient in DORMATE is mebutamate. Additional details are available on the mebutamate profile page.
Summary for DORMATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 34 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DORMATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DORMATE
US Patents and Regulatory Information for DORMATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medpointe Pharm Hlc | DORMATE | mebutamate | TABLET;ORAL | 017374-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |